SEC Filings

SEC Filings
Home / SEC Filings

SEC Filings

Form DEF 14A
PROTALIX BIOTHERAPEUTICS, INC. filed this Form DEF 14A on 04/12/2019
Document Outline
Entire Document (1684.6 KB)
Subdocument 1 - DEF 14A - DEFINITIVE PROXY STATEMENT
Page 1 - UNITED STATES
Page 2 - N/A
Page 3 - NOTICE OF 2019 ANNUAL MEETING OF STOCKHOLDERS
Page 4 - Protalix BioTherapeutics, Inc.
Page 5 - How Do I Vote?
Page 6 - What am I Voting On?
Page 7 - Approval of non-binding advisory resolution on executive compensation
Page 8 - Please complete your proxy and return it as instructed so your vote can be counted.
Page 9 - Do I Need a Ticket to Attend the Annual Meeting?
Page 10 - SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT
Page 11 - N/A
Page 12 - Section 16(a) Beneficial Ownership Reporting Compliance
Page 13 - PROPOSAL 1: ELECTION OF DIRECTORS
Page 14 - Moshe Manor.
Page 15 - Aharon Schwartz, Ph.D.
Page 16 - The Board s Role in Risk Oversight
Page 17 - Board and Committee Meetings
Page 18 - Contacting the Board of Directors
Page 19 - Compensation of Directors
Page 20 - MANAGEMENT
Page 21 - Family Relationships
Page 22 - Performance Bonus.
Page 23 - Severance and Change in Control Benefits.
Page 24 - Grants of Plan-Based Awards
Page 25 - Outstanding Equity Awards at Fiscal Year-End
Page 26 - Yoseph Shaaltiel, Ph.D.
Page 27 - Pay Ratio Disclosure
Page 28 - N/A
Page 29 - Impact of Israeli Tax Law
Page 30 - Certain relationships and related transactions
Page 31 - AUDIT COMMITTEE REPORT
Page 32 - PROPOSAL 2: ADVISORY VOTE ON EXECUTIVE COMPENSATION
Page 33 - PROPOSAL 3: RATIFICATION OF APPOINTMENT OF
Page 34 - SOLICITATION OF PROXIES
Page 35 - HOUSEHOLDING OF PROXY MATERIALS
Page 36 - N/A